INTASYL Trademark

Trademark Overview

On Thursday, July 6, 2023, a trademark application was filed for INTASYL with the United States Patent and Trademark Office. The USPTO has given the INTASYL trademark a serial number of 98073145. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 18, 2024. This trademark is owned by Phio Pharmaceuticals Corp.. The INTASYL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, hematology and in tissue and organ regeneration, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, liver diseases and disorders, antifungal, anti-infective, antiviral preparations and antibiotics
intasyl

General Information

Serial Number98073145
Word MarkINTASYL
Filing DateThursday, July 6, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, hematology and in tissue and organ regeneration, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, liver diseases and disorders, antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, August 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePhio Pharmaceuticals Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752
Party NamePhio Pharmaceuticals Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Trademark Events

Event DateEvent Description
Monday, July 10, 2023NEW APPLICATION ENTERED
Sunday, August 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 18, 2024ASSIGNED TO EXAMINER
Monday, March 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 14, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

intasyl disorders system preparations pharmaceutical diseases treatment prevention caused bacteria ocular